Dr. Reddy's Laboratories share news, announcements and annual reports
NSE: DRREDDYBSE: 500124Pharmaceuticals & BiotechnologyMid Cap
Dr. Reddy's Laboratories Limited · Face value ₹1 Face value. The nominal value of one share as the company issued it, the unit its share capital is counted in and a dividend can be stated as a percentage of; it has no link to the share price. Face value in the glossary · Listed Aug 1986 on BSE, May 2003 on NSE
Last close ₹1,345.00up ₹9.60 (0.72%)BSE ₹1,338.50
Share price at the NSE close on 29 Oct 2026. Previous close ₹1,335.40.
29 Oct: open ₹1,343.50, high ₹1,352.80, low ₹1,336.10
52-week range of traded prices to 29 Oct 2026
₹1,101.00Low, 23 Jul 2026₹1,414.90High, 29 Jun 2026
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies. Market capitalisation: how it is worked out
- ₹1,12,264 Cr104th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. Price to earnings, trailing: how it is worked out
- 40.10
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Price to book: how it is worked out
- 2.89
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- 0.59%
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it.
- 7.5%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet.
- 6.0%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Sep 2026.
- 0.15
- Volume, NSEVolume. Shares traded on the last trading day; delivery is the part buyers kept rather than sold again the same day. Volume in the glossary
- 20,20,77261.4% delivered
Dr. Reddy's Laboratories dividends
23 filed, newest first.
May 2025
May 2024
May 2023
May 2021
May 2019
May 2018
May 2017
May 2016
May 2015
12 May · Dividend
Dr. Reddy's Laboratories Limited has informed the Exchange that the Board of Directors of the Company at its meeting held on May 12, 2015 have recommended a final dividend of Rs.20/- (400%) per equity share of Rs.5/- face value, for the financial year 2014-15.
May 2014
13 May · Dividend
Dr. Reddy's Laboratories Limited has informed the Exchange that the Board of Directors of the Company at its meeting held on May 13, 2014 have recommended a final dividend of Rs.18/- (360%) per equity share of Rs.5/- face value, for the financial year 2013-14..13 May · Dividend
Dr. Reddy's Laboratories Limited has informed the Exchange that the dividend on equity shares, if declared by the shareholders at the ensuing Annual Genera! Meeting, will be credited / despatched on or after August 07, 2014.
May 2013
14 May · Dividend
Dr. Reddy's Laboratories Limited has informed the Exchange that the dividend on equity shares, if declared by the shareholders at the ensuing Annual Genera! Meeting, will be credited / despatched on or after August 07, 2013.14 May · Dividend
Dr. Reddy's Laboratories Limited has informed the Exchange that the Board of Directors of the Company at its meeting held on May 14, 2013 have recommended a final dividend of Rs.15/- (300%) per equity share of Rs.5/- face value, for the financial year 2012-13.
May 2012
11 May · Dividend
Dr. Reddy'S Laboratories Limited has informed the Exchange that the Board of Directors of the Company have recommended a final dividend of Rs.13.75 (275%) per equity share of Rs.5/- face value, for the financial year 2011-12. The dividend on equity shares, if declared by the shareholders at the ensuing Annual General Meeting, will be credited/ dispatched on or after July 27, 2012.
May 2011
13 May · Dividend
Dr. Reddy'S Laboratories Limited has informed the Exchange that the Board of Directors of the Company at its meeting held on May 13, 2011, have recommended a final dividend of Rs.11.25 (225%) per equity share of Rs.5/- face value, for the financial year 2010-11. The dividend on equity shares, if declared by the shareholders at the ensuing Annual General Meeting, will be credited / despatched on or after July 28, 2011.
Jun 2010
29 Jun · Dividend
Dr. Reddy'S Laboratories Limited has informed the Exchange that the dividend, which may be declared at the Annual General Meeting scheduled to be held on July 23, 2010, shall be paid to the shareholders on or after July 30, 2010.
May 2010
6 May · Dividend
Dr. Reddy'S Laboratories Limited has informed the Exchange that the Board of Directors at its meeting held on May 06, 2010 have recommended a final dividend of Rs.11.25 (225%) per equity share of Rs.5/- face value, subject to the approval of shareholders at the ensuing Annual General Meeting.
May 2009
18 May · Dividend
Dr. Reddy's Laboratories Ltd. has informed the Exchange that the Board of Directors of the Company at its meeting held on May 18, 2009 have recommended a final dividend of 125% i.e. Rs. 6.25 per equity share of Rs. 5/- face value, subject to the approval of shareholders at the ensuing Annual General Meeting.
Jul 2008
7 Jul · Dividend
Dr. Reddy'S Laboratories Ltd. has informed the Exchange that the dividend, which may be declared at the Annual General Meeting scheduled to be held on July 22, 2008, shall be paid to the shareholders on or after July 29, 2008.
May 2008
20 May · Dividend
Dr. Reddy'S Laboratories Ltd. has informed the Exchange that the Board of Directors of the Company at its meeting held on May 20, 2008 have recommended a final dividend of 75% i.e. Rs. 3.75 per share of the face value of Rs. 5 subject to the shareholders approval.
May 2007
18 May · Dividend
Dr. Reddy'S Laboratories Ltd. has informed the Exchange that the Board of Directors at its meeting held on May 18, 2007 have recommended a final dividend of 75% i.e. Rs. 3.75 per share of face value of Rs.5 on the enhanced share capital due to bonus issue in August 2006.